Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

December 2019

Feature

Perspectives
12/17/2019
Charles Saunders, MD
Abstract: The Oncology Care Model has reached yet another major milestone, releasing its year-three results in August 2019. Though participants have shared concerns over potential weaknesses in the program, like...
Abstract: The Oncology Care Model has reached yet another major milestone, releasing its year-three results in August 2019. Though participants have shared concerns over potential weaknesses in the program, like...
...
12/17/2019
Journal of Clinical Pathways
Research Reports
12/17/2019
Ashley E Glode, PharmD, BCOP
S Lindsey Davis, MD
Supriya K Jain, MD
Megan D Marsh, PA
Lisa J Wingrove, RD
Tracey E Schefter, MD
Karyn Goodman, MD, MS
Lindel CK Dewberry, MD
Martin D McCarter, MD
Laura Melton, PhD
Michelle Bunch, CSW
Abstract: A standard treatment recommendation for esophageal cancer patients with stage IB-IIIB disease is for neoadjuvant chemoradiation followed by surgery. This trimodality therapy can be difficult for patients to...
Abstract: A standard treatment recommendation for esophageal cancer patients with stage IB-IIIB disease is for neoadjuvant chemoradiation followed by surgery. This trimodality therapy can be difficult for patients to...
...
12/17/2019
Journal of Clinical Pathways

Column

Counterpoint
12/17/2019
Winston Wong, PharmD, Editor-in-Chief
Dr Wong responds to the Viewpoint by Dr Valuck and colleagues, contemplating and evaluating the current quality measures used in care today. He asserts that, rather than trying to develop, revise, and modify quality...
Dr Wong responds to the Viewpoint by Dr Valuck and colleagues, contemplating and evaluating the current quality measures used in care today. He asserts that, rather than trying to develop, revise, and modify quality...
Dr...
12/17/2019
Journal of Clinical Pathways
Viewpoint
12/17/2019
Tom Valuck, MD, JD—Blog Editor
David Blaisdell
Theresa Schmidt, MA
Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...
Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...
...
12/17/2019
Journal of Clinical Pathways
Business of Pathways
12/17/2019
Sean McElligott, MS
Ira Klein, MD, MBA, FACP—Column Editor
While societally we are still debating the best way to finance health care, we do all agree that when a  therapy is available to alleviate illness and suffering, we should find a way to make it available to patients....
While societally we are still debating the best way to finance health care, we do all agree that when a  therapy is available to alleviate illness and suffering, we should find a way to make it available to patients....
While...
12/17/2019
Journal of Clinical Pathways
Trending From ACCC
12/17/2019
JCP Editors
This spring, the Association of Community Cancer Centers (ACCC) is excited to feature Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, at the ACCC 46th Annual Meeting & Cancer...
This spring, the Association of Community Cancer Centers (ACCC) is excited to feature Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, at the ACCC 46th Annual Meeting & Cancer...
This...
12/17/2019
Journal of Clinical Pathways

Department

Pathways in Practice
12/17/2019
Vernon Sondak, MD
Nikhil Khushalani, MD
Evan Wuthrick, MD
In this series, we speak with cancer care practitioners about how pathways are being used in their practices, how they are being applied in a particular disease state, and what challenges remain for treatment...
In this series, we speak with cancer care practitioners about how pathways are being used in their practices, how they are being applied in a particular disease state, and what challenges remain for treatment...
In...
12/17/2019
Journal of Clinical Pathways
Research in Review
12/17/2019
JCP Editors
ASTRO, Congress Urge CMS to Adjust Radiation Oncology APM Congressional leaders from both political parties issued a series of oversight letters to the Centers for Medicare and Medicaid Services in recent...
ASTRO, Congress Urge CMS to Adjust Radiation Oncology APM Congressional leaders from both political parties issued a series of oversight letters to the Centers for Medicare and Medicaid Services in recent...
...
12/17/2019
Journal of Clinical Pathways

Insights

Interview
12/17/2019
JCP Editors
At the Community Oncology Alliance’s (COA) 10th National Payer Exchange Summit on Oncology Payment Reform (October 28-29, 2019; Tysons Corner, VA), Terrill Jordan, president and chief executive officer, Regional...
At the Community Oncology Alliance’s (COA) 10th National Payer Exchange Summit on Oncology Payment Reform (October 28-29, 2019; Tysons Corner, VA), Terrill Jordan, president and chief executive officer, Regional...
At the...
12/17/2019
Journal of Clinical Pathways

News

Conference Coverage
12/17/2019
JCP Editors
The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100...
The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100...
The...
12/17/2019
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement